diclofenac has been researched along with Congestive Ophthalmopathy in 2 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloise, W | 1 |
| Mimura, LY | 1 |
| Moura, J | 1 |
| Nicolau, W | 1 |
| Vondrichova, T | 1 |
| de Capretz, A | 1 |
| Parikh, H | 1 |
| Frenander, C | 1 |
| Asman, P | 1 |
| Aberg, M | 1 |
| Groop, L | 1 |
| Hallengren, B | 1 |
| Lantz, M | 1 |
2 other studies available for diclofenac and Congestive Ophthalmopathy
| Article | Year |
|---|---|
Treatment of mild to moderate Graves' ophthalmopathy with sodium diclofenac: a pilot study.
Topics: Adult; Aged; Cyclooxygenase 2 Inhibitors; Diclofenac; Female; Graves Ophthalmopathy; Humans; Male; M | 2011 |
COX-2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves' ophthalmopathy.
Topics: Adipocytes; Adipogenesis; Cell Differentiation; Cyclooxygenase 2; Dexamethasone; Diclofenac; Gene Ex | 2007 |